<--- Back to Details
First PageDocument Content
Metastatic breast cancer / Ribbon symbolism / Circulating tumor cell / Carcinoembryonic antigen / Colorectal cancer / Integrin / Metastasis / Cancer / Transforming growth factor beta / Medicine / Oncology / Breast cancer
Metastatic breast cancer
Ribbon symbolism
Circulating tumor cell
Carcinoembryonic antigen
Colorectal cancer
Integrin
Metastasis
Cancer
Transforming growth factor beta
Medicine
Oncology
Breast cancer

Original Article Annals of

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Download Document from Source Website

File Size: 413,10 KB

Share Document on Facebook

Similar Documents

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

DocID: 1uQqF - View Document

Jose Falcon Father, Co-Survivor and Veteran Tour de Pink Rider My name is Jose Falcon and I am the proud father and caregiver to my only daughter, Kayla Falcon. She was diagnosed with Stage 4 Metastatic breast cancer at

DocID: 1trwM - View Document

Medicine / Health / Clinical medicine / Ribbon symbolism / RTT / Breast cancer / Metastatic breast cancer / Oncology / Bone metastasis / Radiation therapy / Brain metastasis / Metastatic liver disease

· METASTATIC BREAST CANCER · Assessing Treatment Response in Metastatic Breast Cancer Shlomit Strulov Shachar, MD, and Hyman B. Muss, MD Abstract

DocID: 1rmV3 - View Document

Medicine / Clinical medicine / Transplantation medicine / Graft-versus-host disease / Hematopoietic stem cell transplantation / Breast cancer / Treatment of cancer / Chemotherapy / Metastatic breast cancer / Graft versus tumor effect / Cell therapy / Lumpectomy

Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer

DocID: 1riiF - View Document

Health / Medicine / Clinical medicine / Ribbon symbolism / RTT / Breast cancer / Metastatic breast cancer / CCL2 / Friedrich Miescher Institute for Biomedical Research / Metastasis / Tumor microenvironment / Angiogenesis

Media release, October 23, 2014 Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scienti

DocID: 1rf3r - View Document